中國華融(02799.HK)料引戰增資對復牌後股價具積極意義
內媒報道,中國華融(02799.HK)副總裁王文傑表示,引入戰略投資者爲公司增資,對復牌後股價具有積極的意義,按每股淨資產而言,增發後的每股淨資產將由0.46元人民幣(下同)提升至0.75元,有大幅溢價,大幅增強全體股東的權益,同時充分說明5家投資者認可華融的投資價值,看好公司長期發展。
他強調,管理層始終高度重視和關注公司在資本市場上的表現,亦充分認識到二級市場股價取決於公司的經營業績等內在因素,亦受宏觀經濟監管政策導向、行業趨勢、市場情緒等多方面的外在因素影響,認爲現時首要任務是努力經營,提升業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.